Amisulpride in Schizophrenic Acute Phase Patients

The Use of Amisulpride in Schizophrenic Acute Phase Patients.

To collect the safety and response of using Amisulpride in acute schizophrenic patients

Inclusion Criteria:

• Patient diagnosed as Diagnostic and Statistical Manual of Mental Disorder, 4th edition, as paranoid, disorganized or undifferentiated type of schizophrenia in acute episode

Exclusion Criteria:

• Patients previously treated with amisulpride
• Patients have comorbidity which may interfere with the treatment or follow-up
• Patients currently taking depot antipsychotics (at least 30 days washout period is needed)
• Patients currently/ or recently (< 3 months) withdrawn from drug or alcohol abuse
• Pregnant or lactation

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.